--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--------
Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 14.030
- +0.230+1.67%
Close Dec 13 16:00 ET
- 14.030
- 0.0000.00%
Post 16:00 ET
361.66MMarket Cap-12.49P/E (TTM)
14.040High12.950Low171.35KVolume13.680Open13.800Pre Close2.35MTurnover1.31%Turnover Ratio1275.45P/E (Static)25.78MShares22.00052wk High1.72P/B184.21MFloat Cap12.33052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM7.90%Amplitude12.330Historical Low13.714Avg Price1Lot Size
Contineum Therapeutics Key Stats
Contineum Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Contineum Therapeutics Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data